NEW YORK, Feb. 12, 2019 /PRNewswire/ -- Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasersof Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) securities from December 22, 2014 through February 8, 2019, who have incurred losses on their investments.
As a result of this news, Vanda's stock price fell on Monday February 11, 2019, by $0.95 per share or 5% on heavy volume.
Vanda investors should contact Robert Finkel at (212) 759-4600 or (877) 370-7703 or at email@example.com.
Wolf Popper has successfully recovered billions of dollars for defrauded investors. The firm's reputation and expertise have been repeatedly recognized by the courts, which have appointed the firm to major positions in securities litigation. See www.wolfpopper.com.
Attorney Advertising: Prior Results Do Not Guarantee A Similar Outcome.
Wolf Popper LLPRobert C. Finkel845 Third AvenueNew York, NY 10022Tel.: (212) 451-9620Tel.: (877) 370-7703Fax: (877) 370-7704Email: firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/wolf-popper-llp-announces-investigation-on-behalf-of-investors-in-vanda-pharmaceuticals-inc-300794056.html
SOURCE Wolf Popper LLP
Subscribe to our Free Newsletters!